Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression

被引:25
|
作者
Lee, M. R. [1 ]
Jayant, R. D. [2 ]
机构
[1] NIAAA, Sect Clin Psychoneuroendocrinol & Neuropsychophar, Bethesda, MD 20892 USA
[2] Texas Tech Univ, Sch Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Amarillo, TX 79106 USA
基金
美国国家卫生研究院;
关键词
Neuropeptides; Oxytocin; Blood-brain barrier (BBB); Receptor mediated transcytosis (RMT); CRISPR/Cas9-gRNA; CARRIER-MEDIATED TRANSPORT; DRUG-DELIVERY; CEREBROSPINAL-FLUID; GENE-EXPRESSION; OXYTOCIN; NANOPARTICLES; PEPTIDES; VASOPRESSIN; PASSAGE; SYSTEMS;
D O I
10.1007/s00441-018-2959-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The blood-brain barrier (BBB) is a structural and functional barrier between the interstitial fluid of the brain and the blood; the barrier maintains the precisely controlled biochemical environment that is necessary for neural function. This constellation of endothelial cells, macrophages, pericytes, and astrocytes forms the neurovascular unit which is the structural and functional unit of the blood-brain barrier. Peptides enter and exit the CNS by transport systems expressed by the capillary endothelial cells of the neurovascular unit. Limiting the transport of peptides and proteins into the brain are efflux transporters like P-gp are transmembrane proteins present on the luminal side of the cerebral capillary endothelium and their function is to promote transit and excretion of drugs from the brain to the blood. Nanocarrier systems have been developed to exploit transport systems for enhanced BBB transport. Recent approaches for enhancing endogenous peptide expression are discussed.
引用
收藏
页码:287 / 293
页数:7
相关论文
共 50 条
  • [1] Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression
    M. R. Lee
    R. D. Jayant
    Cell and Tissue Research, 2019, 375 : 287 - 293
  • [2] New approaches to in vitro models of blood-brain barrier drug transport
    Terasaki, T
    Ohtsuki, S
    Hori, S
    Takanaga, H
    Nakashima, E
    Hosoya, K
    DRUG DISCOVERY TODAY, 2003, 8 (20) : 944 - 954
  • [3] Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain
    Pardridge, WM
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2003, 6 (05) : 683 - 691
  • [4] Prediction of blood-brain barrier penetration
    Jorgensen, FS
    Jensen, LH
    Capion, D
    Christensen, IT
    RATIONAL APPROACHES TO DRUG DESIGN, 2001, : 281 - 285
  • [5] Strategies to assess blood-brain barrier penetration
    Di, Li
    Kerns, Edward H.
    Carter, Guy T.
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (06) : 677 - 687
  • [6] PENETRATION OF CATECHOLAMINES THROUGH BLOOD-BRAIN BARRIER
    ZAKUSOV, VV
    TOLMACHE.NS
    VYSOTSKA.NB
    BIULLETEN EKSPERIMENTALNOL BIOLOGII I MEDITSINY, 1972, 73 (05): : 64 - &
  • [7] PENETRATION OF BLOOD-BRAIN BARRIER BY METRONIDAZOLE AND TINIDAZOLE
    JOKIPII, AMM
    MYLLYLA, VV
    HOKKANEN, E
    JOKIPII, L
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1977, 3 (03) : 239 - 245
  • [8] Penetration of Intact Blood-Brain Barrier by Doripenem
    Margetis, K.
    Dimaraki, E.
    Charkoftaki, G.
    Vryonis, E.
    Markantonis, S.
    Boutos, N.
    Archontaki, H.
    Sakas, D. E.
    Valsami, G.
    Skoutelis, A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (07) : 3637 - 3638
  • [9] PENETRATION OF SUGARS ACROSS BLOOD-BRAIN BARRIER
    EIDELBERG, E
    FISHMAN, J
    HAMS, ML
    JOURNAL OF PHYSIOLOGY-LONDON, 1967, 191 (01): : 47 - +
  • [10] PENETRATION OF CATECHOLAMINES THROUGH BLOOD-BRAIN BARRIER
    ZAKUSOV, VV
    VYSOTSKAYA, NB
    TOLMACHEVA, NS
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE,USSR, 1972, 73 (05): : 547 - +